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Park, MarylandABSTRACT Slow diffusion of the lipids in conventional all-atom simulations of membrane systems makes it difficult to sample
large rearrangements of lipids and protein-lipid interactions. Recently, Tajkhorshid and co-workers developed the highly mobile
membrane-mimetic (HMMM) model with accelerated lipid motion by replacing the lipid tails with small organic molecules. The
HMMMmodel provides accelerated lipid diffusion by one to two orders of magnitude, and is particularly useful in studying mem-
brane-protein associations. However, building an HMMM simulation system is not easy, as it requires sophisticated treatment of
the lipid tails. In this study, we have developed CHARMM-GUI HMMM Builder (http://www.charmm-gui.org/input/hmmm) to pro-
vide users with ready-to-go input files for simulating HMMM membrane systems with/without proteins. Various lipid-only and
protein-lipid systems are simulated to validate the qualities of the systems generated by HMMM Builder with focus on the basic
properties and advantages of the HMMM model. HMMM Builder supports all lipid types available in CHARMM-GUI and also
provides a module to convert back and forth between an HMMM membrane and a full-length membrane. We expect HMMM
Builder to be a useful tool in studying membrane systems with enhanced lipid diffusion.INTRODUCTIONOne of the challenging aspects in molecular simulations of
lipid membranes is predicting how chemical compounds
and macromolecules (peptides, proteins, and polymers)
bind to and insert into these membranes and how the
membranes respond to the binding (1–3). Even for short
peptides, studying their interactions with membranes can
be challenging (2) due to the relatively slow diffusion
(~107 cm2/s) of glycerophospholipids (4,5). As a result,
lipid mixing and membrane-induced peptide responses
occur over long timescales. Peptide secondary structures
can be influenced by the membrane environment, as exem-
plified by the folding and unfolding of peptides at the mem-
brane interface by antimicrobial peptides (6) or intrinsically
disordered proteins like a-synuclein (7). Long timescales
are also needed for antimicrobial polymers that disturb the
lipid membrane (1).
The long timescales required present unique challenges in
studying both the folding and insertion of transmembrane
and peripheral membrane proteins using traditional molecu-
lar dynamics (MD) simulations (8–11). Since membrane
binding of these proteins occurs on microsecond or longer
timescales, the access to specialized high-performance com-
puters, such as the Anton supercomputer (12), is oneSubmitted August 5, 2015, and accepted for publication October 9, 2015.
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For example, binding of the oxysterol binding protein of
yeast (Osh4) to model membranes on a microsecond time-
scale was studied by MD simulation using Anton (11).
Although this is useful and serves as a standard to compare
alternative methods, limited access to such resources makes
it intractable to fully probe many different protein-mem-
brane systems and conditions. Most MD simulation studies
of membrane anchoring domains have starting models that
are fully or partially embedded and thus require a priori
knowledge of approximate membrane binding regions and
their orientation and insertion depth with respect to the
membrane (8).
To overcome the timescale and sampling issues, alterna-
tive methods have been used to improve sampling beyond
the capability of unbiased standard MD. Replica-exchange
MD (REMD) (13) has been extensively used for studying
peptide folding in a water solvent (14). The key to this
method is using replicas at different temperatures to ex-
change conformations and probe peptide conformations.
Temperature replicas must be used with caution in mem-
brane systems, as membranes undergo phase transitions
near physiological conditions and are only stable over a
small range of temperatures. Therefore, more recently, the
use of a random walk in surface tension (not temperature)
has been shown to enhance sampling of peptides in the
bilayer while maintaining membrane structure (15). Otherhttp://dx.doi.org/10.1016/j.bpj.2015.10.008
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exchange with solute tempering (REST) (17), have also
shown promise in accelerating timescales in membrane sys-
tems. Accelerated MD adds a boost potential to flatten the
energy surface and allow for easy barrier crossing (16).
This has been successfully applied to membranes with a
speedup of two- to threefold compared to unbiased MD
(18). REST is used for membranes with tempering of the
lipid, and the solvent temperature is fixed. This method
was shown to increase the diffusion rate of lipids by an order
of magnitude compared to unbiased MD (17).
Another approach is to study a model system where the
composition of the membrane accelerates lipid sampling.
The highly mobile membrane-mimetic (HMMM) model
(19) utilizes a biphasic setup (8) by using HMMM lipids
with truncated acyl chains (generally three to five acyl
carbons) and an organic solvent to represent the hydropho-
bic membrane core. The solvent used to date, 1,1-dichloro-
ethane (DCLE), is liquid at standard temperatures and
pressures, hydrophobic enough to mimic the membrane
interior, and also has a small molecular weight that maxi-
mizes its diffusion constant (20). This made DCLE a natural
choice among many other alternative solvents tested for the
biphasic model that evolved into the HMMM model (8).
Free-energy calculations have shown that this model
accurately represents interactions between the membrane
and peripheral membrane proteins (21). The main advantage
of the HMMM model is that the lipid diffusion is enhanced
by one to two orders of magnitude, depending on the density
of the HMMM lipids at the interface (19). Similar to sur-
face-tension-based REMD, the increased surface tension re-
sults in a decrease in lipid packing and an increase in lipid
diffusion (15). However, the HMMM model does not
require use of REMD but instead uses unbiased conven-
tional MD, allowing for accelerated sampling. One of the
main applications of the HMMM model is to study how pe-
ripheral membrane proteins or their membrane-binding do-
mains bind to the membrane interface (20). For example,
binding of the g-carboxyglutamic-acid (GLA)-rich domain
to an HMMM dioleoyl-phosphatidylcholine (DOPC) mem-
brane was found to occur in 50-ns MD simulations (19),
where the membrane simulations of full-length (not trun-
cated) lipids required substantially longer timescales even
with an applied force (22). The HMMM model has been
used to explore a wide variety of membrane-associated
problems that require enhancement in lipid diffusion (20),
e.g., peripheral protein membrane anchoring (23), TM helix
orientation (24), and protein (25–29) and lipid (30) insertion
into biological membranes.
In this work, to facilitate wider use of the HMMMmodel,
we describe HMMM Builder, a new tool developed
in CHARMM-GUI (http://www.charmm-gui.org) (31).
CHARMM-GUI provides a web-based graphical user inter-
face to generate various molecular simulation systems and
input files (for CHARMM (32), NAMD (33), GROMACS(34), AMBER (35), OpenMM (36), and CHARMM/
OpenMM) to facilitate and standardize the usage of
common and advanced simulation techniques (37–39).
Within the framework of Membrane Builder (37,40,41) in
CHARMM-GUI, HMMM Builder (http://www.charmm-
gui.org/input/hmmm) facilitates easy system building with
the HMMM lipids by automatic conversion of all full-length
lipid types available in Membrane Builder to the corre-
sponding HMMM lipids. The input files generated are ready
for use with CHARMM, NAMD, and GROMACS.
In the following, we describe the setup of HMMM
Builder and the steps required by users to generate their
own systems in detail. To illustrate that HMMM Builder
is robust and well suited for various types of membrane
simulations, we provide results for a series of example sys-
tems, including single-lipid and mixed-lipid bilayers and
peptide-membrane systems.MATERIALS AND METHODS
System building
The construction of membrane systems in HMMM Builder follows the five
general steps in CHARMM-GUI Membrane Builder (31,37,40,41). In
step 1, a protein structure (for protein-membrane systems) can be read in
through Protein Data Bank (PDB) Reader (42) either by uploading a
PDB structure file containing single or multiple chains or by typing a
PDB ID from the PDB (43)/Orientations of Proteins in Membranes
(OPM) (44) database. In step 2, if necessary, the protein can be aligned
to and/or translated along the z axis (by definition, a bilayer is centered
at z ¼ 0), and pore water can be generated in the case of a protein with a
channel or more extensive lumen. In step 3, the system size is determined
based on the user-specific input, and lipid-like pseudoatoms are packed to
determine the initial positions of lipid headgroups in the xy plane. In this
step, as the HMMM-related options, a user can choose the position to
trim an acyl chain (the default is to use acyl carbon number 6 as the terminal
carbon, and sterol tails are not trimmed) and the per-lipid area ratio of an
HMMM lipid with respect to the corresponding full-length lipid (the default
is 1.1). In step 4, system components including full-length lipids, ions, and
water box are generated. A DCLE box is also generated by duplicating a
preequilibrated cubic DCLE box whose density is 0.0073 molecule/A˚3.
In step 5, the acyl tails of full-length lipids are trimmed based on the option
in step 3; an example of a full-length and a trimmed palmitoyl-oleoyl-phos-
phatidylcholine (POPC) is shown in Fig. S1 in the SupportingMaterial. The
DCLE box from step 4 is overlaid on the trimmed membrane, and the over-
lapping DCLE molecules are removed. All the components are assembled
into a final system, and the simulation input files for NPT (constant particle
number, pressure, and temperature), NPAT (constant particle number, pres-
sure, surface area, and temperature), or NPgT (constant particle number,
pressure, surface tension, and temperature) ensembles are generated.Conversion between HMMM and full-length
membranes
In addition to HMMM system building, HMMM Builder supports conver-
sion between HMMM and full-length lipid systems. The full-to-HMMM
conversion is identical to the procedures to build HMMM systems. How-
ever, HMMM-to-full is more complicated because HMMM lipid tails are
more flexible than the same atoms in full-length lipids. To obviate this dif-
ficulty, before the conversion to a full lipid, the position of the last carbon
atom in an HMMM lipid is changed to align the last carbon-carbon vector toBiophysical Journal 109(10) 2012–2022
2014 Qi et al.the z axis. The missing coordinates in the converted full-length lipids are
then copied from a library of lipid structures with an additional check to
avoid bad contacts and penetration of lipid tails into ring structures in lipids
and proteins.Simulation protocol
All equilibration and production simulations were performed using NAMD
2.9 (33) with the NPT ensemble and the CHARMM36 force field (45–48).
The van der Waals interactions were smoothly switched off at 10–12 A˚ by a
force-based switching function (49). The particle-mesh Ewald algorithm
was used to calculate electrostatic forces (50). A time step of 2 fs was
used in all simulations. Temperature was maintained at 310 K using Lange-
vin dynamics with a coupling coefficient of 1 ps1. The Nose´-Hoover Lan-
gevin-piston method (51,52) was used to maintain constant pressure at 1 bar
with a piston period of 50 fs and a piston decay of 25 fs. To limit fluctuation
of short-tailed lipids along the membrane normal and to prevent their occa-
sional diffusion into the bulk solution (i.e., surfactant-like behavior), the
HMMM lipids were restrained using weak harmonic potentials (with a
force constant of 0.5 kcal/mol/A˚2 for systems with cholesterols (CHOLs)
and 0.05 kcal/mol/A˚2 for CHOL-free systems) applied to the z-positions
of C21 and C31 (carbonyl carbon) atoms (even for production) (20). In
addition, several restraints were applied to lipid tails, water, and DCLE
molecules during equilibrations (see Table S1).Trajectory analysis
Trajectory analysis was performed with CHARMM (32), VMD (53), and
MDAnalysis (54). The area per lipid was calculated using the Voronoi dia-
gram (see Table S2 for the atoms used to represent each lipid). The diffusion
constant was calculated from the slope of the lateral mean-square displace-
ment (MSD),
MSDðtÞ ¼ 4Dt ¼  jrðt þ t0Þ  rðt0Þj2; (1)
whereD is the diffusion constant, r is the x-y positional vectors, t is the time
interval ranging from 0 to 0.8  tsim, t0 is the starting point for MSD calcu-
lations, and tsim is the total simulation time. The MSD value was averaged
over all lipids from both leaflets with corrections to remove the leaflet drift.
The lateral pressure profile from NAMD output was extracted with the
Harasima contour (55), in which the normal component, pNðzÞ, in the pres-
sure, pðzÞ ¼ pLðzÞ  pNðzÞ, cannot be obtained (56). Because the bilayer
systems in this study are in equilibrium, the normal component, pNðzÞ,
was calculated from
pN ¼ L1z
ZLz=2
Lz=2
pLðzÞ dz; (2)
where Lz is the box size in the z direction. The first moment of the pressure
profile for each leaflet was calculated asF
0ð0Þupper ¼
dF
dR1

R1 ¼ 0
¼ 
ZN
0
z pðzÞ dz (3)
Z0
F
0ð0Þlower ¼
N
z pðzÞ dz; (4)
where F is the free energy of the membrane per unit of lipid area, R1 is the
membrane curvature, and p(z) is the lateral pressure profile. The firstmoment of the pressure profile for the whole bilayer was calculated asBiophysical Journal 109(10) 2012–2022F
0ð0Þbilayer ¼ F
0ð0Þupper  F
0ð0Þlower: (5)
The mean residence time in the mixed-lipid systems was calculated ac-
cording to the method described in Impey et al. (57). For two lipid types A
and B, whose lipid numbers are NA and NB, a contact time series between
lipid i from type A and lipid j from type B, pijðt0; t0 þ t; tÞ, is set to 1 if
these two lipids are in contact at time t0 and t0 þ t and are separated for no
longer than the tolerance time, t* (20 ps in the current study), and 0 other-
wise. Here, two lipids are in contact if the minimal distance between the
heavy atoms of these lipids is <4.5 A˚. To make a fair comparison between
HMMM and full-length lipids, only the heavy atoms shared by the
HMMM and full-length lipids were used in the contact calculations.
The average number of contacts between type A and type B as a function
of the time interval, t, is
nðtÞ ¼ 1
tmax  t
Xtmaxt
t0 ¼ 1
XNA
i¼ 1
XNB
j¼ 1
pijðt0; t0 þ t; tÞ; (6)
where tmax is the total simulation time. When t0 ¼ 0, n(0) is the average
number of contacts between types A and B during the simulation. Themean residence time of two lipid types can be estimated by calculating
n(t)/n(0) from the trajectory and fit the data to an exponential decay func-
tion, exp(t/t), where t is the mean residence time. In this study, we fitted
n(t)/n(0) up to t ¼ 10 ns for HMMM lipids and 30 ns for full-length lipids.
The fitting is an approximate method, but it is enough for the purpose of
comparing the behavior of HMMM and full-length lipids. The mean and
standard errors were obtained by dividing the whole trajectory into five
segments and repeating the calculation on each segment. We also calcu-
lated the contact time series, pijðt0; t0 þ t; tÞ, based on the neighboring
pairs in the Voronoi diagram, but the main conclusion did not change
(data not shown).RESULTS AND DISCUSSION
To illustrate membrane simulations with HMMM Builder,
we tested several systems including three single-lipid sys-
tems, four mixed-lipid systems, and two peptide-membrane
systems (Table 1). Replacing the lipid tails with DCLE mol-
ecules in the membrane hydrophobic core makes the mem-
brane more fluid. For a given number of lipids, however, it is
not easy to determine the optimal number of DCLE mole-
cules, because the system behavior depends not only on
lipid type, but also on other factors, such as temperature
and lipid chain saturation. To consider these facts,
HMMM Builder allows the user to change the per-lipid
area ratio (RSA) of the HMMM lipids relative to the corre-
sponding full-length lipids. As the thickness of the DCLE
layer is roughly constant, varying the per-lipid area ratio
is equivalent to varying the volume that DCLE molecules
will occupy in the final system, thereby changing the num-
ber of DCLE molecules in the system. In other words, if RSA
> 1, the initial system will have a larger xy system size (than
the system based on the area per full-length lipid) and thus
more DCLE molecules will be filled in the membrane
hydrophobic core, likely leading to faster lipid diff-
usion. To show the effect of using different RSA values
and to determine a reasonable default value, we tested six
TABLE 1 Lipid components and scaling factors of the example systems
Number of Lipids in Each Leaflet RSA
Single-Lipid System
POPC 64 POPC 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
POPE 64 POPE 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
POPS 64 POPS 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
Mixed-Lipid System
MIX1 40 POPC/40 POPE/20 POPS 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
MIX2 41 POPC/41 POPE/16 POPS/1 POPI24/1 POPI25 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
MIX3 40 POPC/40 POPE/20 TOCL2 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
MIX4 34 POPC/33 PSM/33 CHOL 0.8, 0.9, 1.0, 1.1, 1.2, 1.3
MARCKS-ED Peptide Systems
MARCKS1 60 POPC/60 POPE/30 POPS 1.1
MARCKS2 61 POPC/61 POPE/24 POPS/2 POPI24/2 POPI25 1.1
POPC, palmitoyl-oleoyl-phosphatidylcholine; POPE, palmitoyl-oleoyl-phosphatidylethanolamine; POPS, palmitoyl-oleoyl-phosphatidylserine; POPI24,
palmitoyl-oleoyl-phosphatidylinositol-(4,5)-bisphosphate with protonation on P4; POPI25, palmitoyl-oleoyl-phosphatidylinositol-(4,5)-bisphosphate with
protonation on P5; TOCL2, tetraoleoyl cardiolipin; PSM, n-palmitoyl sphingomyelin; CHOL, cholesterol;
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tems (Table 1).Single-lipid systems
The three single-lipid bilayers (POPC, POPE, and POPS)
were simulated for 100 ns to investigate the basic properties
of HMMM membranes. As a control, we also simulated the
corresponding full-length lipid systems for 150 ns. The per-
lipid area of the HMMM lipid is larger than the area of the
corresponding full-length lipid in all three bilayer systems
(Fig. 1 A), which is accompanied by a decrease in the
HMMM bilayer thickness (compared to the thickness of
the full-length membranes) at a given RSA (Figs. 1 B and
S2). As a balance between per-lipid area and bilayer thick-
ness, we use RSA ¼ 1.1 as the default value in HMMM
Builder; this value can be changed by the user in step 3
(see Materials and Methods). The HMMM lipids are ex-
pected to diffuse much faster than full-length lipids. To es-
timate the diffusion constant, we performed linear fitting of
the mean-square displacement as a function of time interval
(Fig. S3). The HMMM lipids show a diffusion constant be-
tween 2  107 and 10  107 cm2/s, which is ~2–10 times
faster than the diffusion constants of the full-length lipids,A B
FIGURE 1 Single-lipid HMMM membrane properties: (A) surface area per
and POPS HMMM membranes as a function of the per-lipid area ratio (RSA)
are presented as the ratio of an HMMM membrane to a full-length membrane,
color, go online.which are 1.02  107 (POPC), 0.43  107 (POPE), and
0.32  107 (POPS) cm2/s (Fig. 1 C). In general, the
HMMM lipids diffuse faster at larger RSA, which is due to
less packing between the lipids at larger RSA.
As the HMMM membrane expands in the xy plane and
shrinks along the z axis, it is important to make sure that
the DCLE density is still reasonable. In all three systems,
the DCLE densities at the bilayer center are very close to
each other, regardless of RSA (Fig. 2). The density is
~0.0068 molecule/A˚3, somewhat lower than the initial den-
sity (0.0073 molecule/A˚3) in the DCLE box to build the sys-
tem. The thickness of the DCLE layer at the half-maximum
density increases with increasing RSA, in accordance with
the change in bilayer thickness (Fig. S4 A). The number
of DCLE molecules per trimmed acyl tail carbon atom
ranges from 0.15 to 0.25 at different RSA values
(Fig. S4 B). When RSA is ~1.0–1.1, the number is close to
the value used in a previous study, in which ~14 acyl tail
carbons are replaced with three DCLE molecules
(i.e., 0.21 DCLE molecules per trimmed carbon atom)
(20). In addition, ~1% of the DCLE molecules escaped to
the bulk during the simulation, which we believe is negli-
gible and is due to the natural partition coefficient of
DCLE between lipid and solution.C
lipid, (B) bilayer thickness, and (C) diffusion constant of POPC, POPE,
and in the full-length membrane. In (A) and (B), the area and thickness
with the standard deviations shown by the error bars. To see this figure in
Biophysical Journal 109(10) 2012–2022
A B C
FIGURE 2 Density profiles of DCLE molecules in pure (A) POPC, (B) POPE, and (C) POPS HMMMmembranes with different RSA. To see this figure in
color, go online.
2016 Qi et al.Lateral pressure in membranes plays an important role in
the regulation of protein function (58,59). Due to the liquid
nature of DCLE, an HMMM membrane is not expected to
have the same pressure profile as in a full-lipid membrane.
To quantify the difference, we calculated the pressure pro-
files of the HMMM and full-length POPC, POPE, and
POPS membranes (Fig. 3). All HMMM membranes feature
a profile similar to that of the full-length membrane outside
the DCLE layer, and a neutral pressure at the membrane
center (due to the liquid nature of DCLE). In contrast, the
full-length membranes show a positive peak at the mem-
brane center, which arises from the repulsive interactions
between the lipid tails. This behavior is expected from the
nature of HMMM, where the small DCLE molecules act
as a bulk organic solvent that would have a vanishing shear
modulus (analogous to bulk water). In HMMM membranes,
the positive pressure at the lipid headgroup and tail interface
(~z¼512 A˚) is higher than the pressure in the correspond-
ing full-length membranes, which compensates for the
neutral pressure at the membrane center and keeps the inte-
gration of the lateral pressure profile along the z axis at zero
(i.e., zero surface tension) under the NPT condition.
The first moment of the pressure profile, F
0ð0Þ, provides
the free-energy derivative at planar curvature (60,61), with
a positive/negative value indicating a preference to bend
toward the headgroup/tail direction. In all HMMM systems,
the monolayers (upper leaflet or lower leaflet) show a posi-
tive F
0ð0Þ around 0.1 at RSA¼ 0.8, suggesting that the lipidsA B
FIGURE 3 Pressure profiles of HMMM and full-length (A) POPC, (B) POPE,
not shown. To see this figure in color, go online.
Biophysical Journal 109(10) 2012–2022are packed too compactly and the monolayer would bend in
the headgroup direction (i.e., positive curvature) at this RSA
(Fig. S5). With increasing RSA, the F
0ð0Þ of the monolayer
approaches zero in POPC and POPE but remains negative
in POPS, which likely arises from the intrinsic curvature
preference of the POPS lipid. Not surprisingly, the F
0ð0Þ
of the whole bilayer is close to zero in all HMMM and
full-length membranes due to the imposed symmetry of
the membrane and the z-position restraints in the HMMM
membrane. Although the full-length membrane’s F
0ð0Þ
values are not reproduced exactly in the HMMM mem-
branes, our results suggest that using RSA > 1.0 is still
reasonable for NPT simulations.Mixed-lipid systems
HMMM Builder supports all lipid types available in
CHARMM-GUI. To demonstrate the simulations of
different lipid mixtures, we tested four mixed-lipid systems
(Table 1). The per-lipid areas in systems MIX1–3 are larger
than the full-lipid areas (Fig. S6), similar to the results for
single-lipid systems. However, in MIX4, POPC, PSM, and
CHOL have smaller areas than the full-length lipids, with
RSA values around 0.9 (Fig. S6). A possible cause is the
favorable interactions between PSM and CHOL making
them pack more compactly in the HMMM membrane.
The HMMM lipids in MIX1–3 show a speedup in diffusion
similar to that observed in the single-lipid systems (Figs. 4 AC
and (C) POPS bilayers. For clarity, the profiles at RSA¼ 0.8, 1.0, and 1.2 are
A B C
FIGURE 4 Mixed-lipid HMMMmembrane properties: (A) diffusion constant, (B) mean residence time, and (C) pressure profile at different RSA. In MIX2,
the residence times between PIP2 and other lipid types are not calculated due to lack of data. To see this figure in color, go online.
CHARMM-GUI HMMM Builder 2017and S7). In MIX2, POPI24 and POPI25 show a large varia-
tion in diffusion constant, because only two POPI24/
POPI25 molecules were present in each leaflet, so that the
data obtained in the simulations are not sufficient to make
a good estimate. In MIX4, due to the decreased fluidity
caused by CHOL, POPC diffuses more slowly than it does
in CHOL-free HMMM systems (MIX1-3), but still much
faster than the full-length POPC lipids in the control system
with the same lipid composition (Fig. S7). To compare the
lipid mixing in HMMM and full-length membranes, we
calculated the mean residence time, t, between lipid types,
which characterizes the persistence of one lipid type in con-
tact with another one (see Materials and Methods). In all
four systems, the full-length lipids have larger t and thus
slower mixing than the corresponding HMMM lipids
(Figs. 4 B and S8). Moreover, the HMMM lipids show a
decrease of t at large RSA, which is in agreement with the
faster diffusion of the HMMM lipids at larger RSA.The pressure profiles in systemsMIX1–4 are similar to the
profiles in the single-lipid systems, all showing a neutral pres-
sure at the HMMMmembrane center and a positive pressure
peak at the full-lipid membrane center (Fig. 4 C). In MIX4,
the pressure in the HMMM membrane is larger than that in
the full-lengthmembrane, which is likely due tomore rigidity
caused by the large restraint force constant (0.5 kcal/mol/A˚2
inMIX4 and 0.05 kcal/mol/A˚2 inMIX1–3; seeMaterials and
Methods) on the lipid carbonyl atoms in the HMMM mem-
brane. Due to this large restraint force, the membrane thick-
ness in MIX4 does not change with respect to RSA and the
membrane is thinner than the corresponding full-lengthmem-
brane at all RSAvalues (Fig. S9A). The CHOL in the HMMM
membrane has slightly wider tilt-angle distributions than
CHOL in the full-length membrane due to the fluidity of
the DCLE molecules (Fig. S9 B). However, the densities of
the CHOL heavy atoms and O3 atoms match those in the
full-length membrane well (Fig. S9, C and D).Biophysical Journal 109(10) 2012–2022
2018 Qi et al.As expected, the first moment of the pressure profiles for
the whole bilayer is close to zero in all mixed-lipid systems
(Fig. S10). The monolayer F
0ð0Þ decreases as RSA increases,
similar to the trend observed in the pure-lipid systems. In
MIX4, the full-length F
0ð0Þ values for the monolayers do
not agree with each other, which is likely due to insufficient
sampling caused by the slow diffusion in this system.MARCKS-ED membrane association
As a practical application of HMMM Builder, we conduct-
ed a simulation of peptide-membrane association. The 25-
amino-acid peptide derived from the effector domain of
myristoylated alanine-rich C kinase substrate protein
(MARKCS-ED) was chosen as a model system (62). This
peptide is enriched with both basic and hydrophobic resi-
dues (sequence: KKKKK RFSFK KSFKL SGFSF
KKNKK), and is able to sequester anionic lipids such as
PIP2 through nonspecific electrostatic interactions
(63,64). To compare the effect of PIP2 lipids, two simula-
tion systems were set up: system MARCKS1, consisting
of POPC, POPE, and POPS, and system MARCKS2, con-
sisting of POPC, POPE, POPS, and PIP2 (Table 1). Two
copies of the peptide were placed 45 A˚ above and below
the membrane center, respectively (Fig. 5 A), and each sys-
tem was simulated for 300 ns with five replicates. In
MARCKS-ED simulations, the center of mass of the pep-
tides was restrained to be between 48 and 48 A˚ along
the z axis.
In both systems, the peptide binds quickly to the mem-
brane within 50 ns, initially driven by favorable electro-
static interactions between the peptide and the membrane
(Fig. 5, B and C). To check the convergence of each resi-
due’s burial depth, we calculated the z-positions of each
side chain relative to the lipid phosphate groups in 50-ns
blocks (Fig. 6). MARCKS1 shows good convergence
with the phenylalanine (residues 7, 9, 13, 18, and 20)
and leucine (residue 15) residues buried deeply in the
membrane, whereas the lysine residues at the terminiFIGURE 5 MARCKS-ED-membrane association systems. (A) An initial str
spheres with lysine colored in blue, phenylalanine and leucine in orange, and oth
POPS in purple sticks, POPE in silver sticks, and PIP2 in red sticks; ions and w
MARCKS-ED in (B) MARCKS1 and (C) MARCKS2 simulations (each with fiv
simulation, and the black lines mark the average position of the lipid phosphate
Biophysical Journal 109(10) 2012–2022remain on the membrane surface. This binding mode is
in agreement with the previous results showing that the
peptide adopts a U-shape when it binds to membranes
(65). However, in the MARCKS2 system, the z-positions
show large variations between independent simulations.
A clustering analysis shows that the MARCKS-ED struc-
tures are concentrated on fewer clusters in MARCKS2
than in MARCKS1 (Fig. S11 A). It is likely that PIP2 binds
to the peptide and slows down the conformational sam-
pling of the peptides in MARCKS2. In addition, the pep-
tide structure is more compact in terms of radius of
gyration in MARCKS2, suggesting that the peptide is
less extended in the presence of PIP2 (Fig. S11 B). These
results suggest that PIP2 has a large impact on the pep-
tide’s conformation.
The burial depth of 12 out of the 25 residues has been
determined experimentally by replacing the corresponding
residue with a spin label and measuring the electron para-
magnetic resonance spectrum (66). For both MARCKS1
and MARCKS2, the depths of only a few residues agree
with the experimental estimates with bulky spin labels.
A likely reason for the MD/experiment disagreement is
that the experiment measures the depth of the spin label
attached to a cysteine single mutant, not the wild-type
amino acid. The S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihy-
dro-1H-pyrrol-3-yl)methyl methanesulfonothioate (MTSL)
spin label is 8–10 A˚ from the Ca and likely interacts
with the membrane (67). Therefore, further simulations
with spin label at specific residues are needed to clarify
this discrepancy and better quantify interactions between
MTSL and the membrane.
Adding phosphatidylserine and PIP2 lipids to PC vesicles
enhances the binding between MARCKS-ED and mem-
branes (68). To compare the sequestration effect on different
lipids, we calculated the percentage of lipids in contact with
MARCKS-ED (Fig. 7). The sequestration effect is strongest
to PIP2, followed by POPS, and then POPE and POPC (see
Table S3 for the two-sample t-test results), in accordance
with the amount of negative charge in each lipid type. It isucture of the MARCKS2 simulation system. MARCKS-ED is shown in
er residues in white; DCLE is shown in blue spheres, POPC in orange sticks,
ater molecules are not shown for clarity. (B and C) The center of mass of
e replicates). Each colored line represents one peptide in each independent
groups. To see this figure in color, go online.
AB
FIGURE 6 Relative z-positions of each residue in
50-ns blocks in (A) MARCKS1 and (B) MARCKS2.
The lipid phosphate groups are recentered to be
located at z ¼ 0 and the membrane center is located
at z < 0. Each line represents one peptide; there are
10 lines from the five independent simulations. The
stars indicate the experimental estimates from Qin
et al. (66). To see this figure in color, go online.
CHARMM-GUI HMMM Builder 2019worth noting that the most probable number of PIP2 in con-
tact with MARCKS-ED is 3, which is close to the experi-
mental estimation (69).HMMM to full-lipid conversion
HMMM Builder provides a facility to convert back and
forth between an HMMM system and a full-length lipidFIGURE 7 Percentages of lipids in contact with MARCKS-ED and a snapsho
PIP2. A contact is counted when the minimal distance between the heavy atom
peptide. The averages and standard errors of percentages from 150 ns to 300 n
spheres with lysine colored in blue, phenylalanine and leucine in orange, and oth
POPS in purple sticks, POPE in silver sticks, and PIP2 in red sticks. To see thissystem. To illustrate this function, we converted the last
snapshot of one of the MARCKS1 system to a full-length
lipid system and simulated the full-length lipid system for
100 ns (Fig. 8 A). As expected, the box size of the full-
lipid system extends along the z axis and shrinks along
the xy plane (Fig. 8 B). The peptides remain associated
with the membrane (Fig. 8 C), as shown in the z-position
time series for each residue (Fig. S12).t of the MARCKS2 system showing a MARCKS-ED in contact with three
s from a lipid and the peptide is <4.5 A˚. Each colored line represents one
s are shown in blue numbers. In the snapshot, MARCKS-ED is shown in
er residues in white; DCLE is shown in blue spheres, POPC in orange sticks,
figure in color, go online.
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FIGURE 8 Simulation of the converted full-length lipid system. (A) The last snapshot of the full-length lipid MARCKS1 simulation. Lipids are shown in
sticks; peptides are shown in spheres, with lysine colored in blue, phenylalanine and leucine in orange, and other residues in white. (B) The time series of the
system box size (x and y are constrained to be identical in simulations). (C) Time series of the center of mass of the peptides. The black lines indicate the
average position of the lipid phosphate groups. To see this figure in color, go online.
2020 Qi et al.CONCLUSIONS
In this study, we present HMMM Builder, a new module in
CHARMM-GUI to build membrane simulation systems us-
ing the HMMM model. To show the capability of HMMM
Builder, several single-lipid and mixed-lipid bilayers were
set up to investigate the basic properties of HMMM mem-
branes under the NPT ensemble. Due to the liquid nature of
the DCLE molecules used to represent the membrane core,
the HMMM membranes show larger per-lipid area, faster
lipid diffusion and mixing, and neutral pressure in the
DCLE layer (with close resemblance of the full-length
membrane pressure profile outside the DCLE layer). The
MARCKS-ED peptide is simulated as an example to study
peptide-membrane association using mixed-lipid mem-
branes generated by HMMM Builder. The simulations
show good convergence in the POPC/POPE/POPS bilayer,
highlighting the advantage of using the HMMM model.
However, in the POPC/POPE/POPS/PIP2 bilayer, different
replicates of the peptide show some variations in the resi-
due burial depth due to strong interactions between
MARCKS-ED and PIP2. It should be emphasized that the
HMMM model accelerates diffusion of lipids and other
molecular species within the lipids, but not much the inter-
nal degrees of freedom of the peptide. Finally, HMMM
Builder provides conversions between HMMM and full-
length lipid systems, allowing the user to easily take advan-
tage of both HMMM and full-length membranes for the
system of interest.SUPPORTING MATERIAL
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